Stockscreener 앱 받기
4.01
1.78%
0.07
전일 마감가:
$3.94
열려 있는:
$4.01
하루 거래량:
223.90K
Relative Volume:
0.93
시가총액:
$123.41M
수익:
$72.35M
순이익/손실:
$-45.34M
주가수익비율:
-2.5533
EPS:
-1.5705
순현금흐름:
$-32.43M
1주 성능:
+1.01%
1개월 성능:
-4.30%
6개월 성능:
+19.35%
1년 성능:
-23.62%
1일 변동 폭
$3.92
$4.08
1주일 범위
$3.82
$4.135
52주 변동 폭
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.01 | 123.41M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-05 | 개시 | Northland Capital | Outperform |
| 2025-11-20 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2025-08-08 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
AVITA Medical (RCEL) Showcases RECELL GO Clinical Data at UK Con - GuruFocus
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - Investing News Network
AVITA Medical’s burn treatment used in 17 U.K. patients - Stock Titan
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AVITA Medical Inc (RCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVITA Medical Inc (RCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
AVITA Medical Inc (RCEL) Institutional Confidence - TradingKey
RCEL to Host Virtual Meeting on June 23 - GuruFocus
AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4 - Stock Titan
Insider Buying: Joseph Woody Acquires Shares of AVITA Medical In - GuruFocus
Avita Medical director Woody Fralin buys $20,800 in common stock - Investing.com
AVITA Medical (RCEL) director adds 5,200 shares in open-market buy - Stock Titan
Avita Medical director Woody Fralin buys $20,800 in common stock By Investing.com - Investing.com Australia
Avita Medical director Woody Fralin buys $41,900 in stock By Investing.com - Investing.com India
Avita Medical director Woody Fralin buys $41,900 in stock - Investing.com
Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med - GuruFocus
Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical, Inc. Issues Warrant Certificate to Perceptive Credit Holdings V, LP – Details, Terms, and Signatures - Minichart
AVITA Medical Issues Warrant to Perceptive Tied to $60 Million Credit Facility - TradingView
[8-K] AVITA Medical, Inc. Reports Material Event - Stock Titan
AVITA Medical (RCEL) registers 650,000 shares tied to Perceptive $3.40 warrant - Stock Titan
AVITA Medical (RCEL) director makes 10,000-share open-market stock purchase - Stock Titan
AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus - Bez Kabli
AVITA Medical (RCEL) director receives RSU and stock option awards - Stock Titan
AVITA Medical (NASDAQ: RCEL) grants RSUs and stock options to director - Stock Titan
AVITA Medical (RCEL) director Michael Tarnoff receives RSU and option grants - Stock Titan
AVITA Medical (RCEL) director receives RSU and option awards in equity grant - Stock Titan
AVITA Medical (RCEL) director Suzanne Crowe granted RSUs and stock options - Stock Titan
Director at AVITA Medical (NASDAQ: RCEL) granted RSUs and options - Stock Titan
Avita Medical, Inc. Ratifies Appointment of Grant Thornton LLP as Independent Registered Public Accounting Firm - marketscreener.com
Insider Buying: Joseph Woody Acquires 20,000 Shares of AVITA Med - GuruFocus
AVITA MEDICAL INC-2026 ASM BOARD CHAIR SCRIPT - Moomoo
AVITA Medical (NASDAQ: RCEL) investors approve director pay, warrants and extra equity capacity - Stock Titan
Director Woody Fralin buys 20,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical (RCEL) CFO acquires 5,000 shares through ESPP plan - Stock Titan
AVITA Medical (RCEL) CEO adds 5,000 shares through ESPP purchase - Stock Titan
Intention to Cease Coverage of Avita Medical - Morningstar
Intention to Cease Coverage of IDP Education, Polynovo, Avita, and Clinuvel - Morningstar
RCEL Stock Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) Stages a Notable Rebound, Testing Key Resistance ZoneALMA Signal - thelegaladvocate.com
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical Q1 2026 Earnings: EPS Misses Estimates as Strategic Investments ContinueRevenue Growth Report - thelegaladvocate.com
RCEL Q1 2026 Earnings: EPS Misses Estimates, Stock Gains Amid Operational ProgressPeak Earnings Alert - thelegaladvocate.com
Avita Medical (RCEL) Gains 2.2% as Shares Test Key Resistance at $4.81Composite Profile - Newser
Avita Medical Q1 earnings call highlights - MSN
Morgans says these ASX shares could rise 12% to 20% - MSN
Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
자본화:
|
볼륨(24시간):